Torray LLC Vertex Pharmaceuticals Inc Transaction History
Torray LLC
- $678 Million
- Q3 2024
A detailed history of Torray LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Torray LLC holds 15,751 shares of VRTX stock, worth $7.39 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
15,751
Previous 13,938
13.01%
Holding current value
$7.39 Million
Previous $6.53 Million
12.12%
% of portfolio
1.08%
Previous 1.02%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,725Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.6 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.54 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.22 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...